Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Knowledge of HCV Status & Drug Treatment Programs

PLoS One; ePub 2018 Apr 27; Fisher, et al

Knowledge of hepatitis C virus (HCV) status differentially influences the relationship between treatment history and current injection risk behaviors, a recent study suggests. The study sought to assess the role of drug treatment programs and knowledge of HCV status, and how they influence current injection-related risk. Data were collected in 2012 by the New Orleans arm of the National HIV Behavioral Surveillance. Respondent driven sampling was used to recruit a sample of people who inject drugs (PWID). Univariate, bivariate, and linear regression analyses were performed. Researchers found:

  • The sample consisted of 473 participants.
  • History of drug treatment is associated with sterile syringe use among PWID.
  • Knowledge of HCV status modifies the relationships between history of drug treatment and sterile syringe use.

Citation:

Fisher KA, Cahill LM, Broyles S, Rorke M, Robinson WT. Knowledge of hepatitis C status moderates the relationship between history of drug treatment and sterile syringe use. [Published online ahead of print April 27, 2018]. PLoS One. doi:10.1371/journal.pone.0196157.

This Week's Must Reads

Glecaprevir/pibrentasvir Can Reduce HCV Tx Duration, Hepatol Int; ePub 2018 May 29; Abutaleb, et al

Estimates of HCV by Race and Sex in US, BMC Infect Dis; ePub 2018 May 16; Hall, et al

Efficacy of DAA Therapy for HCV in Older Adults, J Am Geriatr Soc; ePub 2018 May 25; Mazzarelli, et al

HCV Treatment in People Who Inject Drugs, Open Forum Infect Dis; ePub 2018 May 23; Alimohammadi, et al

Risk of HCV Among Vulnerable Populations, J Viral Hepat; ePub 2018 May 31; Aisyah, et al

Must Reads in Hepatitis

Glecaprevir/pibrentasvir Can Reduce HCV Tx Duration, Hepatol Int; ePub 2018 May 29; Abutaleb, et al

Estimates of HCV by Race and Sex in US, BMC Infect Dis; ePub 2018 May 16; Hall, et al

Efficacy of DAA Therapy for HCV in Older Adults, J Am Geriatr Soc; ePub 2018 May 25; Mazzarelli, et al

HCV Treatment in People Who Inject Drugs, Open Forum Infect Dis; ePub 2018 May 23; Alimohammadi, et al

Risk of HCV Among Vulnerable Populations, J Viral Hepat; ePub 2018 May 31; Aisyah, et al